Metabolomics in NEC: An Updated Review

Area of Science:

• Neonatal medicine
• Gastroenterology
• Biomarker discovery
• Omics technologies

Background:

• Necrotizing enterocolitis (NEC) is a critical gastrointestinal emergency in newborns, particularly premature infants.
• High mortality (approx. 25%) and severe long-term complications underscore the urgency of addressing NEC.
• Current diagnostic methods for NEC are limited by non-specific symptoms and poor test accuracy, hindering early intervention.

Purpose of the Study:

• To review the application of metabolomics and microbiota analysis in understanding NEC pathophysiology.
• To explore the potential of omics technologies for identifying non-invasive biomarkers for NEC prediction and early diagnosis.
• To discuss the future role of metabolomic profiling in clinical diagnostics for NEC.

Main Methods:

• Review of current literature on metabolomics and microbiomics applied to necrotizing enterocolitis.
• Analysis of the interplay between host and microbiota in NEC pathogenesis.
• Exploration of omics data for identifying diagnostic and predictive biomarkers.

Main Results:

• Metabolomics and microbiomics present a synergistic approach to unraveling NEC complexity.
• Understanding microbiota-host interactions can reveal metabolic pathways crucial to NEC.
• Potential for developing specific biomarkers through advanced omics analyses.

Conclusions:

• Omics technologies, particularly metabolomics and microbiomics, are vital tools for advancing NEC research.
• Identifying specific metabolic fingerprints holds promise for early NEC diagnosis and improved patient management.
• Further research into microbiota-host crosstalk can lead to novel diagnostic strategies for this devastating neonatal condition.